Division of Rheumatology, Fondazione Policlinico Universitario "A. Gemelli", Institute of Rheumatology, Catholic University School of Medicine, Rome, Italy.
Division of Internal Medicine, Fondazione Policlinico Universitario "A. Gemelli", Institute of Internal Medicine, Catholic University School of Medicine, Rome, Italy.
Mediators Inflamm. 2017;2017:5230374. doi: 10.1155/2017/5230374. Epub 2017 Oct 23.
Rheumatoid arthritis (RA) is a chronic, definitely disabling, and potentially severe autoimmune disease. Although an increasing number of patients are affected, a key treatment for all patients has not been discovered. High-mobility group box-1 (HMGB1) is a nuclear protein passively and actively released by almost all cell types after several . HMGB1 is involved in RA pathogenesis, but a convincing explanation about its role and possible modulation in RA is still lacking. Microbiome and its homeostasis are altered in patients with RA, and the microbiota restoration has been proposed to patients with RA. The purpose of the present review is to analyze the available evidences regarding HMGB1 and microbiome roles in RA and the possible implications of the crosstalk between the nuclear protein and microbiome in understanding and possibly treating patients affected by this harmful condition.
类风湿关节炎(RA)是一种慢性、致残性且潜在严重的自身免疫性疾病。尽管越来越多的患者受到影响,但尚未发现针对所有患者的关键治疗方法。高迁移率族蛋白 B1(HMGB1)是一种核蛋白,在经历多种应激后几乎所有细胞类型都会被动和主动释放。HMGB1 参与了 RA 的发病机制,但对于其作用及其在 RA 中可能的调节作用仍缺乏令人信服的解释。RA 患者的微生物组及其内稳态发生改变,并且已经向 RA 患者提出了恢复微生物组的建议。本综述的目的是分析有关 HMGB1 和微生物组在 RA 中的作用的现有证据,以及核蛋白与微生物组之间相互作用在理解和可能治疗受这种有害疾病影响的患者方面的可能意义。